On August 26, 2010, DePuy Orthopaedics, a division of Johnson and Johnson, recalled two types of defective hip implants because of higher-than-expected early failure rates.
The recall affects the ASR XL Acetabular System, which is used for total hip replacements, and the ASR Hip Resurfacing System, which is used in a newer kind of bone-conserving procedure.
Specifically, data has established that five years after the hip was implanted, 12% of patients who had received the ASR Resurfacing System and 13% of patients who received the ASR total hip replacement needed to have it replaced.
The ASR Hip Resurfacing System was only sold outside of the United States, but the ASR XL Acetabular System was sold worldwide.
The two hip systems that have been recalled became available in July 2003. If you had hip surgery after July 2003 and may have received a DePuy ASR hip implant, you should immediately seek legal representation from an experienced pharmaceutical lawyer. Our drug litigation firm, Zoll, Kranz, and Borgess, has been recognized on a national level for its work in pharmaceutical litigation on behalf of victims.
We are also investigating the link between Biomet metal-on-metal hips and their higher rates of failure.
For more information on the DePuy ASR recall or problems with Biomet hips, check out our DePuy ASR Blog. You can also call us toll-free at (888) 841-9623 or email at michelle@toledolaw.com for a confidential review of your claim at no cost.